JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

Core Insights - JCR will present non-clinical data from its novel JUST-AAV gene therapy platform technology at the ESGCT 32nd Annual Congress [1] Company Overview - The presentation will focus on the advancements and findings related to the JUST-AAV gene therapy platform [1]